| Product Code: ETC7373971 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Lung Cancer Liquid Biopsy Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Lung Cancer Liquid Biopsy Market - Industry Life Cycle |
3.4 Grenada Lung Cancer Liquid Biopsy Market - Porter's Five Forces |
3.5 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.6 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Grenada Lung Cancer Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Grenada |
4.2.2 Growing adoption of liquid biopsy as a non-invasive diagnostic tool |
4.2.3 Advances in technology leading to improved accuracy and efficiency of liquid biopsy tests |
4.3 Market Restraints |
4.3.1 High cost associated with liquid biopsy tests |
4.3.2 Limited awareness among healthcare professionals and patients about the benefits of liquid biopsy |
4.3.3 Regulatory challenges and reimbursement issues in Grenada healthcare system |
5 Grenada Lung Cancer Liquid Biopsy Market Trends |
6 Grenada Lung Cancer Liquid Biopsy Market, By Types |
6.1 Grenada Lung Cancer Liquid Biopsy Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By Biomarker Type, 2021- 2031F |
6.1.3 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By CTC (Circulating Tumor Cells), 2021- 2031F |
6.1.4 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By ctDNA (Circulating tumor DNA), 2021- 2031F |
6.1.5 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By Exosomes and RNA, 2021- 2031F |
6.2 Grenada Lung Cancer Liquid Biopsy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By Small CellLung Cancer, 2021- 2031F |
6.2.3 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021- 2031F |
6.3 Grenada Lung Cancer Liquid Biopsy Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By Diagnostic and Imaging Centres, 2021- 2031F |
6.3.3 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Grenada Lung Cancer Liquid Biopsy Market Revenues & Volume, By Academic and Research Centers, 2021- 2031F |
7 Grenada Lung Cancer Liquid Biopsy Market Import-Export Trade Statistics |
7.1 Grenada Lung Cancer Liquid Biopsy Market Export to Major Countries |
7.2 Grenada Lung Cancer Liquid Biopsy Market Imports from Major Countries |
8 Grenada Lung Cancer Liquid Biopsy Market Key Performance Indicators |
8.1 Average turnaround time for liquid biopsy test results |
8.2 Number of healthcare facilities offering liquid biopsy services in Grenada |
8.3 Rate of adoption of liquid biopsy tests among oncologists in Grenada |
8.4 Number of research studies or clinical trials utilizing liquid biopsy technology in Grenada |
8.5 Patient satisfaction with liquid biopsy testing experience |
9 Grenada Lung Cancer Liquid Biopsy Market - Opportunity Assessment |
9.1 Grenada Lung Cancer Liquid Biopsy Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.2 Grenada Lung Cancer Liquid Biopsy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Grenada Lung Cancer Liquid Biopsy Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Grenada Lung Cancer Liquid Biopsy Market - Competitive Landscape |
10.1 Grenada Lung Cancer Liquid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 Grenada Lung Cancer Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here